Exclusive: Prosecutors identify Insys founder as unindicted co-conspirator in opioid case

BOSTON (Reuters) - U.S. prosecutors have identified Insys Therapeutics Inc's billionaire founder as an unindicted co-conspirator in a case accusing six former executives and managers of participating in a scheme that involved bribing doctors to prescribe a fentanyl-based drug, according to a court document.